Purpose:
Dicerna Pharmaceuticals, Inc. is committed to creating a climate and culture that promotes objectivity in research by establishing standards that help ensure that the design, conduct and reporting of Public Health Service (PHS, which includes National Institutes of Health or NIH) funded research is free from bias resulting from financial conflict of interest (FCOI).
Requirements:
In compliance with federal regulations Dicerna Pharmaceuticals requires its employees, including all its investigators and other key personnel participating in a PHS-funded research project to disclose a list of Significant Financial Interests (and those of his/her spouse and dependent children) that could be reasonably expected to bias the design, conduct, or reporting of the project. PIs, Co-PIs, and in some instances, key personnel listed on a proposal for external funding must complete a Financial Conflict of Interest disclosure form (by completing the Dicerna Financial Conflict of Interest form) before submitting a proposal to and expending resources on a sponsored project funded by PHS (NIH, BARDA), NSF or other agencies adopting federal requirements.
Federal regulations regarding financial conflict of interest (FCOI) have been issued by the Department of Health and Human Services and went into effect August 24, 2012.
Links:
The new regulations can be found here: http://grants.nih.gov/grants/policy/coi/fcoi_final_rule.pdf
The Dicerna Financial Conflict of Interest Policy can be found here : Dicerna FCOI Research Policy 2021.
NIH Conflict of Interest Tutorial
Dicerna employees, including investigators and other key personnel are required to complete mandatory training before participating in research funded by PHS. NIH has developed a web-based tutorial that addresses the main requirements of the revised regulation. The tutorial highlights the key Federal requirements for which the employees, including the investigator and other key personnel, Dicerna Pharmaceuticals, and NIH or other PHS-Funded agencies are accountable under the new regulation. http://grants.nih.gov/grants/policy/coi/tutorial2011/fcoi.htm
For more information, visit the following links:
42 CFR Part 50, 45 CFR Part 94 http://grants.nih.gov/grants/policy/coi/fcoi_final_rule.pdf
NIH FCOI http://grants.nih.gov/grants/policy/coi/index.htm
NIH FCOI FAQs http://grants.nih.gov/grants/policy/coi/coi_faqs.htm
NIH FCOI Tutorial http://grants.nih.gov/grants/policy/coi/tutorial2011/fcoi.htm
NSF FCOI http://www.nsf.gov/pubs/policydocs/pappguide/nsf11001/aag_4.jsp#IVA
If you have any remaining questions about the Financial Conflict of Interest Policy or regarding completing the FCOI forms, please contact Mark Wanda at mwanda@dicerna.com.
